Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02406781
Title Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC)
Acronym PEMBROSARC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonié
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.